| Page 36 | Kisaco Research

As AI adoption accelerates across investigations, compliance, and disputes functions, many organisations are moving faster on deployment than on governance. The result: growing pressure from regulators, boards, and internal stakeholders to not just use AI - but to prove it works, is controlled, and is defensible.

This interactive roundtable brings together senior legal, compliance, and investigations leaders to explore how organisations are moving from experimentation to operationalisation - balancing speed, efficiency, and risk. Together, we will discuss what “good” looks like in practice: from evaluating AI outputs and managing model risk, to ensuring auditability, transparency, and trust in high-stakes environments.

Rather than theory, this session focuses on real-world approaches to adopting AI in regulated environments - what’s working, what’s not, and where leading organisations are placing their bets.

Author:

Davide Rocco

Senior Sales Engineer
Relativity

Davide Rocco

Senior Sales Engineer
Relativity

Author:

Diego Hernandez Ronquillo

Manager - Discovery & Data Management - Risk, Regulatory & Forensic
Deloitte

Diego Hernandez Ronquillo

Manager - Discovery & Data Management - Risk, Regulatory & Forensic
Deloitte

Author:

Jessica Hoffmann

Manager- Forensics, Discovery and Data Management
Deloitte

Jessica Hoffmann

Manager- Forensics, Discovery and Data Management
Deloitte
 

Davide Rocco

Senior Sales Engineer
Relativity

Davide Rocco

Senior Sales Engineer
Relativity

Davide Rocco

Senior Sales Engineer
Relativity

 LLMs on bad data hallucinate with confidence. We unpack what "AI-ready" really means for UBO, sanctions, PEP and adverse-media data. Data structured for machines, not humans. Ten years of building this layer before the hype — and why the data, not the model, is the real differentiator in compliance AI.

Author:

Gagik Sargsyan

CEO & Founder
Polixis SA

Gagik Sargsyan

CEO & Founder
Polixis SA
 

Laura Ramsay

Partner
Kilburn & Strode

Laura Ramsay

Partner
Kilburn & Strode

Laura Ramsay

Partner
Kilburn & Strode
  • The Power of the "One Health" Synergy: How startups can leverage the convergence of human medical breakthroughs, plant science research, and animal health innovation to accelerate R&D and commercialization.
  • The Collaborative Ecosystem: Insights into the unique "Innovation Bridge" between Purdue University, Elanco, and future partners.
  • Infrastructure for Growth: Navigating the specialized lab spaces and commercialization support available in Indianapolis, designed to take startups from "seed to scale" faster than traditional tech hubs.
  • Bridging the Gap: How the district facilitates direct access to strategic mentors, regulatory guidance, and academic and corporate partners de-risk the path to market.

Author:

John Stewart

Senior Director, One Health Innovation District and Economic Development
Elanco

John Stewart

Senior Director, One Health Innovation District and Economic Development
Elanco

Author:

Kaethe Beck

Associate Vice President for Strategic Impact in the Life and Health Sciences
Purdue University

Kaethe Beck

Associate Vice President for Strategic Impact in the Life and Health Sciences
Purdue University